
Repligen
(NASDAQ) RGEN
Repligen Financials at a Glance
Market Cap
$6.55B
Revenue (TTM)
$738.26M
Net Income (TTM)
$48.89M
EPS (TTM)
$0.86
P/E Ratio
134.60
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$116.30
Volume
19,194
Open
$115.30
Price
$116.30
Volume
19,194
Open
$115.30
Previous Close
$116.30
Daily Range
$114.55 - $117.68
52-Week Range
$102.97 - $175.77
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$116.30
Volume
19,194
Open
$115.30
Previous Close
$116.30
Daily Range
$114.55 - $117.68
52-Week Range
$102.97 - $175.77
RGEN News
RGEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Repligen
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
2,000
CEO
Olivier Dominique Loeillot, MBA
Website
www.repligen.comHeadquarters
Waltham, MA 02453, US
RGEN Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
8%
Net Income Margin
7%
Return on Equity
2%
Return on Capital
2%
Return on Assets
2%
Earnings Yield
0.74%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.55B
Shares Outstanding
56.33M
Volume
19.19K
Short Interest
0.00%
Avg. Volume
780.21K
Financials (TTM)
Gross Profit
$347.62M
Operating Income
$59.58M
EBITDA
$164.30M
Operating Cash Flow
$117.42M
Capital Expenditure
$23.52M
Free Cash Flow
$93.90M
Cash & ST Invst.
$767.63M
Total Debt
$689.95M
Repligen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$197.91M
+18.1%
Gross Profit
$93.44M
+140.6%
Gross Margin
47.21%
N/A
Market Cap
$6.55B
N/A
Market Cap/Employee
$3.69M
N/A
Employees
1,778
N/A
Net Income
$13.29M
+139.2%
EBITDA
$44.98M
+2031.6%
Quarterly Fundamentals
Net Cash
$77.68M
+9.2%
Accounts Receivable
$158.59M
+18.2%
Inventory
$170.46M
+19.2%
Long Term Debt
$668.39M
-0.4%
Short Term Debt
$21.56M
+42.7%
Return on Assets
1.66%
N/A
Return on Invested Capital
1.98%
N/A
Free Cash Flow
$17.05M
-47.0%
Operating Cash Flow
$25.70M
-34.4%







